simple, direct urinary assay of pyridinium crosslinks and deoxypyridinoline,
useful in identifying current rate of bone loss, lytic bone disease,
and efficacy of bone support therapies.
The Bone Resorption Assessment from Genova
Diagnostic Laboratory can improve the
quality of life for women. This test
elevated levels of bone loss
before excessive damage has occurred. Enables
regular testing of women for resorption
at its most effective-before bone loss
the effectiveness of calcium supplementation to slow bone loss and
Profile $135.00 To order this test click Add
Using the two most specific markers of bone resorption, the Bone
Resorption Assessment measures bone loss accurately and inexpensively.
By discriminating between patients with high and low bone turnover—two
subgroups which benefit from different therapeutic approaches—health
care professionals can prescribe appropriate treatments and monitor
patient compliance and treatment effectiveness.
The Bone Resorption Assessment is also invaluable in studying osteoporosis
and the bone diseases associated with arthritis, metabolic bone
disease, and cancer. The noninvasive urine analysis assays pyridinium
crosslinks and deoxypyridinoline, two collagen crosslinks found
to be more specific for bone resorption than other collagen metabolites,
such as telopeptides.
The Bone Resorption Assessment is a simple urinary hormone test that provides an accurate assessment of the rate of bone turnover in an individual. Hormone testing with the Bone Resorption Assessment allows the practitioner to identify those more likely to develop osteoporosis, to intervene before significant loss has occurred, and to monitor the efficacy of treatment regimens. It examines pyridinium crosslinks and deoxypyridinoline and is useful in identifying current rate of bone loss, lytic bone disease, and efficacy of bone support therapies.
Hormone Testing and Osteoporosis:
- Osteoporosis leads to 1.5 million fractures per year
- Osteoporosis affects more than 50% of healthy American women aged 30-40 who are likely to develop vertebral fractures as they age
- Hormone testing is an important component to identify individuals currently losing bone at an accelerated rate so that effective treatment can begin before significant bone loss has occurred
Measuring Bone Resorption
Pyridinium crosslinks are stabilizers of collagen molecules. Bone collagen contains both pyridinoline (PYD), which is reflective of collagen loss of all types, and its component deoxypyridinoline (DPD), which specifically reflects bone collagen. Presence in the urine of higher than normal amounts of PYD and DPD indicate a rapid rate of bone loss.
Crosslink excretion is greatly increased in patients with osteoporosis, as well as in a number of other conditions. These include Paget´s disease, primary hyperparathyroidism, and osteomalacia. Measurement of PYD crosslinks has also proven useful in arthritic diseases, connective tissue disorders, cancer metastasis, and alcoholic bone disease.
All lab tests can be done through the mail in the privacy of your
own home, except blood tests, we send you to a lab to have your
blood drawn for these. After you pay for the test we mail you the
kit, the results take two weeks, the test results will be mailed
to us and we will call you to go over the results, its that easy!
All tests include the consultation for the report of findings.
Click on test of interest on the right for more information
Call our office for details.
800-956-7083 OR 818-707-3126